期刊文献+

δ胆红素在肝移植术后早期的变化规律及价值 被引量:1

Early profile and clinical significance of serum delta bilirubin after orthotopic liver transplantation
下载PDF
导出
摘要 目的 探讨血清δ胆红素 (δB)在肝移植术后早期的变化规律及临床意义。 方法  2 7例原位肝移植 ,按并发症有无分为 :病情平顺组 ( 10例 ) ,急性排斥反应组 ( 8例 ) ,两组合并为痊愈组 ( 18例 ) ,其余为围手术期死亡组 ( 9例 )。比较各组病人术后每日血清δB的变化。 结果 术后δB占总胆红素 (Totalbilirubin ,TB)的百分比 (δB % ) ,病情平顺组病人逐渐升高 ,2 1天时达 ( 37 5± 11 2 ) %。急性排斥反应发生后 ,δB %由 ( 2 6 4± 9 8) %下降至 ( 2 0 2± 12 7) % (n =8,t=2 12 ,P =0 0 7) ,TB、结合胆红素 (Conjugatedbilirubin ,CB)峰值比排斥反应前基值显著升高 (t=3 75 ,P =0 0 0 7;t=3 5 9,P =0 0 0 9)。术后 14天痊愈组δB % (n =18)明显高于死亡组 (n =9) ,分别为 ( 33 4± 12 2 ) %和 ( 2 2 0± 10 0 ) % (t=2 4 2 ,P =0 0 2 )。 结论 术后 14天时δB %与病人出院时转归有关。在排斥反应的诊断方面 ,血清TB和CB比δB %有更大优势。 Objective To investigate the early variations and clinical value of serum delta bilirubin after orthotopic liver transplantation. Methods Orthotopic liver transplantation was performed in 27 cases.Of them,10 cases were uneventful;8 patients suffered from acute rejection.According to the outcome,18 patients (including 10 uneventful cases and 8 cases with acute rejection) survived while other 9 died.Daily determination of serum delta bilirubin was examined in all patients. Results The changing patterns of serum delta bilirubin were different between uneventful patients and those with acute rejection.For those uneventful patients,δB% tended to increase after operation.On the 21st day after transplantation,it reached(37.5±11.2)%.To the contrary,after acute rejection occurred,δB% decreased from basal level(26.4±9.8)% to(20.2±12.7)%(n=8,t=2.12,P=0.07).Serum concentration of total bilirubin (TB) and conjugated bilirubin (CB) significantly increased after acute rejection arose.The difference between peak and basal level of TB and CB was (150.3±113.2)μmol/L(n=8)and(118.5±93.4)μmol/L(n=8)respectively(t=3.75,P=0.007;t=3.59,P=0.009).On the 14th day after operation,δB% in patients with good outcome(n=18) significantly higher than that in patients who died(n=9)(33.4%±12.2% vs 22.0%±10.0%,t=2.42,P=0.02).Conclusions Two weeks after operations,δB% is correlative to the outcome of the patients.But as for the diagnosis of the acute rejection,δB% shows no advantages over serum TB or CB.
出处 《中国微创外科杂志》 CSCD 2003年第2期177-178,共2页 Chinese Journal of Minimally Invasive Surgery
关键词 肝脏移植 Δ胆红素 急性排斥反应 早期 变化规律 Liver transplantation Delta bilirubin Acute rejection
  • 相关文献

参考文献9

  • 1[1]Igea J, Nuňo J, López-Hervás P, et al. Evaluation of delta bilirubin in the follow-up of hepatic transplantation. Transplant Proc,1999, 31: 2469.
  • 2[2]Higashijima H, Yamasshita H, Makino I, et al. Significance of serum delta bilirubin during obstructive jaundice in dogs. J Surg Res, 1996, 66: 119-124.
  • 3[3]Naoto Kozaki, Shuji Shimizu, Higashijima H, et al. Significance of serum delta-bilirubin in patients with obstructive jaundice. J Surg Res, 1998, 79: 61-65.
  • 4[4]Rosenthal P, Jennings MT. Serum delta bilirubin estimation by an automated method. Eur J Clin Chem Clin Biochem, 1992, 30: 39-41.
  • 5靳振南,宋克征.δ胆红素研究的进展[J].陕西医学检验,1996,11(1):60-63. 被引量:1
  • 6[6]Reed RG, Davidson LK, Burrington CM, et al. Non-resolving jaundice: bilirubin covalently attached to serum albumin circulates with the same metabolic half-life as albumin. Clin Chem,1988, 34: 1992-1994.
  • 7[7]Catherine JC, Ronald OV, Tony RZ, et al. Ektachem bilirubin fraction CB as a predictor of liver transplant rejection. Transplantation,1987, 44: 536-539.
  • 8[8]Wu TW, Levy GA, Samuel Ylu, et al. Delta and conjugated bilirubin as complementary markers of early rejection in liver-transplant recipients. Clin Chem, 1990, 36: 9-14.
  • 9[9]Janen H, Lange R, Erhard J, et al. Serum bile acids in liver transplantation-early indicator for acute rejection and monitor for antirejection therapy. Transpl Int, 2001, 14: 429-437.

二级参考文献2

同被引文献8

  • 1郑树森,吴健.肝移植术后胆道并发症的防治和围手术期处理[J].中华肝脏病杂志,2005,13(3):161-163. 被引量:31
  • 2郑树森.肝脏移植[M].北京:人民卫生出版社,2003.159-164.
  • 3Janen H,Lange R ,Erhard J,et al.Serum bile acids in liver transplantation-early indicator for acute rejection and monitor for antirejection therapy[J].Transpl Int,2001,14: 429-437
  • 4Sing N,Thomas E.Infectious disease in the liver transplant recipient [J].Sem in Gastrointest Dis,1998,9(3): 136
  • 5Neff GW, O'brien CB, Nery J, et al. Outcomes in liver transplant recipients with hepatitis B virus: Resistance and recurrence patters from a large transplant center over the last decade [J].Liver transpl, 2004,10:1 372-1 378
  • 6Nemec P,Ondrasek J, Studenik P,et al,Biliary complications in liver transplant[J].Ann Transplant,2001,6(2):24
  • 7Al-Sebayel MS,Ramirez C,EIIa KA,et al.Vascular complications in the first 100 liver transplantations in Saudi Arabia [J].Int Surg, 2001,86(1).- 33
  • 8Sawyer RG, Punch JD, Incidence and management of biliary complications after 291 liver transplants following the introduction of transcystic stenting[J] .Transplantation, 1998, 66: 1 201 - 1 207

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部